financetom
Business
financetom
/
Business
/
Tech stocks see biggest weekly outflow on record, BofA says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tech stocks see biggest weekly outflow on record, BofA says
Mar 8, 2024 4:24 AM

LONDON (Reuters) -Investors dumped technology stocks at the fastest rate on record and continued to pour money into investment grade bonds and cash equivalents in the week to Wednesday, Bank of America said on Friday, citing data from EPFR.

Tech stocks saw $4.4 billion of outflows in the latest week, their "largest outflow ever" and the first outflow in nine weeks, BofA said in its weekly roundup of fund flows in and out of world markets, without specifying how far back its figures went.

The data covers the week to Wednesday, March 6, when U.S. tech stocks fell sharply. That included Apple, whose shares finished 2.8% lower after a research report showed iPhone sales in China fell 24% year-on-year in the first six weeks of 2024. [.N]

Tech shares have since rebounded somewhat and the S&P 500 hit another closing high on Thursday. Its large gains in recent months have been mainly led by large technology companies.

There were $32 billion of flows into cash and $13.3 billion into investment grade bonds, the largest inflow since September 2020, BofA said.

Cash equivalent money market funds have seen significant inflows over the past year because of high yields on the very short-term government debt they hold.

"$6 trillion to $7 trillion in money market funds and all of it getting 5% in interest ... maybe that's what's giving everyone the confidence to go speculate," BofA said.

Tech aside, equities saw the seventh straight week of inflows, with investors adding $6.9 billion. Real estate stocks stood out with inflows of $1.2 billion, the most in two years.

Crypto funds registered inflows of $1.9 billion in the week. Bitcoin, the world's largest crypto currency by market value, hit a record high of $69,202 on Tuesday, before retreating.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved